Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 2/20 | 0.46 |
| ▸ | SCN4A | P35499 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7087892 | 0.83 | LMNA (0.50) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL11052073 | 0.81 | LMNA (0.53) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL10983129 | 0.80 | CYP1A2 (0.66) | PPARGPPARAMMECYP1A2 | |
| SCHEMBL11134968 | 0.79 | CPA3 (0.57) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL5512521 | 0.78 | LMNA (0.57) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL11115581 | 0.77 | CYP2C19 (0.49) | PPARGPPARALMNAMTNR1AMTNR1B | |
| Ethane SCHEMBL5531789 | 0.77 | LMNA (0.49) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL3728369 | 0.77 | PPARG (0.54) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL5514903 | 0.76 | TBXA2R (0.47) | PPARGPPARALMNAMTNR1AMTNR1B | |
| SCHEMBL27427221 | 0.76 | SLC1A1 (0.61) | PPARGPPARAMMECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1935872-A1 | Process for obtaining the R-enantiomer of salbutamol | Stirling Products Limited (AU) | 2008-06-25 | — | — | EP | disclosed |
| WO-2008070909-A1 | PROCESS FOR OBTAINING THE R-ENANTIOMER OF SALBUTAMOL | STIRLING PRODUCTS LIMITED (AU) | 2008-06-19 | — | — | WO | disclosed |